We report back from The Health Foundation’s conference in London this month exploring the opportunities and challenges posed by AI adoption in healthcare
A new study will use AI and NHS data to predict side effects from drug combinations before they reach patients.
Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme.
The MHRA has outlined moves to deepen collaboration with the US on medical technology regulation, with initiatives to accelerate innovation, strengthen patient safety, and reduce transatlantic barr...
The time it takes to approve clinical trials in the UK has been cut by more than half – from an average of 91 days to just 41 days – after major reforms and the introduction of digital platforms at...
The MHRA’s Criminal Enforcement Unit has launched a number of criminal investigations following a spike in hospital admissions believed to be linked to the use of unlicensed botulinum toxin products.
The UK has become the first country to join a new global network of health regulators focused on the safe, effective use of AI in healthcare.
A reform of how medical devices are regulated in Great Britain takes effect from today (16 June), as part of MHRA's broader transformation of the UK’s medical device regulatory framework.
A Westminster Health Forum event recently looked at the future of the Medtech sector in the UK
Twelve suspects have been arrested in dawn raids in the largest criminal investigation into organised medicines trafficking in the history of the Medicines and Healthcare products Regulatory Agency...
Lawrence Tallon has been appointed as the new chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA).
Kirklees, West Yorkshire £62,474 - £73,056 plus a Market Rate Supplement
Kirklees, West Yorkshire £62,474 - £73,056 plus a Market Rate Supplement